Jazz Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.About JAZZ
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio.
JAZZ Key Statistics
Stock Snapshot
The current Jazz Pharmaceuticals(JAZZ) stock price is $230.02, with a market capitalization of 14.46B. The stock trades at a price-to-earnings (P/E) ratio of -12293.48.
As of 2026-06-27, Jazz Pharmaceuticals(JAZZ) stock has fluctuated between $226.20 and $231.14. The current price stands at $230.02, placing the stock +1.7% above today's low and -0.5% off the high.
The Jazz Pharmaceuticals(JAZZ)'s current trading volume is 821.73K, compared to an average daily volume of 877.28K.
In the last year, Jazz Pharmaceuticals(JAZZ) shares hit a 52-week high of $243.32 and a 52-week low of $105.00.
In the last year, Jazz Pharmaceuticals(JAZZ) shares hit a 52-week high of $243.32 and a 52-week low of $105.00.
JAZZ News
Advertisement Why Jazz Pharmaceuticals stock is back in focus after mixed cancer updates Jazz Pharmaceuticals (JAZZ) is back on investors’ radar after the com...
Key Points Zepzelca's failed trial doesn't derail Jazz's growth strategy. First-line adoption is becoming Zepzelca's biggest opportunity. Management maintain...
Analyst ratings
86%
of 21 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.